Optometry

Latest News


CME Content


An excimer laser offers a number of features that collectively contribute to outstanding outcomes when using this platform to perform LASIK for a range of refractive errors.

Results from 3 years of follow-up in the phase II clinical trial investigating an angle-supported phakic IOL for the treatment of moderate to high myopia indicate this anterior chamber implant provides excellent visual acuity and is associated with accurate predictability of refraction and promising safety.

The safety and efficacy of cataract removal using torsional ultrasound with a proprietary handpiece and phacoemulsification system have been raised to a higher level by a recent software upgrade, according to one expert.

An intraocular device is a new concept in the treatment of age-related macular degeneration that taps into telescopic mirror technology to redesign patients' vision, according to experts.

Ranibizumab for the treatment of macular edema associated with central retinal vein occlusion demonstrated rapid and sustained improvement as early as 7 days after the start of treatment through 6-month interim analysis.

A proprietary surgical microscope allows dynamic control of the red reflex to provide unsurpassed intraocular visualization and to improve the ease and safety of cataract surgery.

Compared with sham injections, monthly injections of 0.3 or 0.5 mg of ranibizumab significantly reduced macular edema and improved best-corrected visual acuity in patients with branch retinal vein occlusion.

Lessons learned from an ongoing retinal implant program at the University of Southern California are being applied to the development of a novel refillable and programmable drug delivery device that could be used in glaucoma management.

A unique fusion protein is being studied to treat age-related macular degeneration, diabetic macular edema, and macular edema secondary to central retinal vein occlusion.

Glaucoma is common in eyes with a keratoprosthesis implanted, and this increases the challenge of disease management, particularly IOP measurement, according to one expert.